| GTSYX | WCMNX | GTSYX / WCMNX | |
| Total Expense Ratio | 0.92 | 1.24 | 74% |
| Annual Report Gross Expense Ratio | 0.92 | 2.04 | 45% |
| Fund Existence | 18 years | 7 years | - |
| Gain YTD | 19.273 | 9.225 | 209% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.73B | 52.4M | 3,294% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 26.91 | 25.42 | 106% |
| Returns for 3 years | 44.47 | 31.21 | 142% |
| Returns for 5 years | -27.71 | -1.40 | 1,981% |
| Returns for 10 years | 9.92 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CGW | 62.38 | 0.58 | +0.93% |
| Invesco S&P Global Water ETF | |||
| NIHI | 51.64 | 0.21 | +0.41% |
| NEOS MSCI EAFE High Income ETF | |||
| RWEM | 37.34 | 0.09 | +0.25% |
| Rayliant Wilshire Nxtgen Emerging Markets Equity ETF | |||
| SPDN | 8.60 | -0.01 | -0.12% |
| Direxion Daily S&P 500® Bear 1X ETF | |||
| HELX | 34.31 | -0.74 | -2.11% |
| Franklin Genomic Advancements ETF | |||